Abstract
In the era of the diseasomes and interactome networks, linking genetics with phenotypic traits in Turner syndrome should be studied thoroughly. As a part of this stratagem, mosaicism of both X and Y chromosome which is a common finding in TS and an evaluation of congenital heart diseases in the different situations of mosaic TS types, can be helpful in the identification of disturbed sex chromosomes, genes and signaling pathway actors. Here we report the case of a mosaic TS associated to four left-sided CHD, including BAV, COA, aortic aneurysms and dissections at an early age. The mosaicism included two cell lines, well-defined at the cytogenetic and molecular levels: a cell line which is monosomic for Xp and Xq genes (45,X) and another which is trisomic for pseudoautosomal genes that are present on the X and Y chromosomes and escape X inactivation: 45,X[8]/46,X,idic(Y)(pter→q11.2::q11.2→pter)[42]. This case generates two hypotheses about the contribution of genes linked to the sex chromosomes and the signaling pathways involving these genes, in left-sided heart diseases. The first hypothesis suggests the interaction between X chromosome and autosomal genes or loci of aortic development, possibly dose-dependent, and which could be in the framework of TGF-β-SMAD signaling pathways. The second implies that left-sided congenital heart lesions involve sex chromosomes loci. The reduced dosage of X chromosome gene(s), escaping X inactivation during development, contributes to this type of CHD. Regarding our case, these X chromosome genes may have homologues at the Y chromosome, but the process of inactivation of the centromeres of the isodicentric Y spreads to the concerned Y chromosome genes. Therefore, this case emerges as an invitation to consider the mosaics of Turner syndrome and to study their phenotypes in correlation with their genotypes to discover the underlying developmental and genetic mechanisms, especially the ones related to sex chromosomes.
Similar content being viewed by others
Abbreviations
- AAAD:
-
Acute type A aortic dissection
- ACTA2:
-
Actin, alpha-2, smooth muscle, aorta [MIM:102620] cytogenetic location:10q23.31
- AGTR1:
-
Angiotensin II receptor type 1 [MIM:106165] cytogenetic location:3q24
- AGTR2:
-
Angiotensin II receptor type 2 [MIM:300034] cytogenetic location:Xq23
- AngII:
-
Angiotensin II
- AS:
-
Aortic stenosis
- AZF:
-
Azoospermia factor
- BAV:
-
Bicuspid aortic valve
- bp:
-
Base pair
- CEP:
-
DNA probe specific for the alpha satellite (centromeric) region
- cGMP:
-
Cyclic guanosine monophosphate
- CHD:
-
Congenital heart disease
- CNV:
-
Copy number variant
- COA:
-
Aortic coarctation
- der(Y):
-
Derivative of Y chromosome
- DNA:
-
Deoxyribonucleic acid
- EDTA:
-
Ethylenediaminetetraacetic acid
- FISH:
-
Fluorescence in situ hybridization
- idic:
-
Isodicentric
- KCl:
-
Potassium chloride
- LSI:
-
Locus-specific identifier probe
- MAT2A:
-
Methionine adenosyltransferase II, alpha [MIM:601468] cytogenetic location:2p11.2
- MFAP5:
-
Microfibrillar-associated protein 5 [MIM:601103] cytogenetic location:12p13.31
- MRI:
-
Magnetic resonance imaging
- MYH11:
-
Myosin, heavy chain 11, smooth muscle [MIM:160745] cytogenetic location:16p13.11
- MYLK:
-
Myosin light chain kinase [MIM:600922] cytogenetic location:3q21.1
- NANOGP1:
-
NANOG homeobox pseudogene 1 (NCBI Gene ID:404635) cytogenetic location:12p13.31
- PCR:
-
Polymerase chain reaction
- PRKG1:
-
Protein kinase, cGMP-dependent regulatory, type I [MIM:176894] cytogenetic location:10q11.2-q21.1
- RHG banding:
-
Reverse banding using heat and giemsa
- SHOX:
-
Short stature homeobox gene [MIM:312865] cytogenetic location:Xp22.33
- SLC2A14:
-
Solute carrier family 2 (facilitated glucose transporter), member 14 pseudogene [MIM:611039] cytogenetic location:12p13.31
- SLC2A3:
-
Solute carrier family 2 (facilitated glucose transporter), member 3 pseudogene [MIM:138170] cytogenetic location:12p13.31
- SMAD 3:
-
Mothers against decapentaplegic, DroSophila, homolog 3 [MIM:603109] cytogenetic location:15q22.33
- SMAD:
-
Contraction of Sma and Mad, homologs of both the Drosophila protein, mothers against decapentaplegic (MAD) and the Caenorhabditis elegans protein SMA from gene sma for small body size
- SRY:
-
Sex-determining Region Y [MIM:480000] cytogenetic location:Yp11.2
- STS:
-
Sequence-tagged site
- TGFBR1:
-
Transforming growth factor-beta receptor, type I [MIM:190181] cytogenetic location:9q22.33
- TGFBR2:
-
Transforming growth factor-beta receptor, type II [MIM:190182] cytogenetic location:3p24.1
- TGF-β:
-
Transforming growth factor-beta
- vs:
-
Versus
- TS:
-
Turner syndrome
- ZFX/Y:
-
Sequences homologous to the human X- and Y-borne zinc finger protein genes
- ZFX:
-
Zinc finger protein, X-linked [MIM:314980] cytogenetic location:Xp22.11
- ZFY:
-
Zinc finger protein, Y-linked [MIM:490000] cytogenetic location:Yp11.2
References
Abdelmoula NB, Amouri A (2005a) Dicentric Y chromosomes. First part: cytogenetic and molecular aspects. Ann Biol Clin (Paris) 63(3):263–278
Abdelmoula NB, Amouri A (2005b) Dicentric Y chromosome. Ann Biol Clin (Paris) 63(4):363–375
Barbier M, Gross MS, Aubart M, Hanna N, Kessler K, Guo DC et al (2014) MFAP5 loss-of-function mutations underscore the involvement of matrix alteration in the pathogenesis of familial thoracic aortic aneurysms and dissections. Am J Hum Genet 95(6):736–743
Berletch JB, Yang F, Xu J, Carrel L, Disteche CM (2011) Genes that escape from X inactivation. Hum Genet 130(2):237–245
Bispo AV, Burégio-Frota P, Oliveira dos Santos L, Leal GF, Duarte AR, Araújo J et al (2014) Y chromosome in Turner syndrome: detection of hidden mosaicism and the report of a rare X;Y translocation case. Reprod Fertil Dev 26(8):1176–1182
Bondy C (2014) Recent developments in diagnosis and care for girls in Turner Syndrome. Adv Endocrinol 2014:231089. https://doi.org/10.1155/2014/231089
Bondy C, Bakalov VK, Cheng C, Olivieri L, Rosing DR, Arai AE (2013) Bicuspid aortic valve and aortic coarctation are linked to deletion of the X chromosome short arm in Turner syndrome. J Med Genet 50(10):662–665
Castro AV, Okoshi K, Ribeiro SM, Barbosa MF, Mattos PF, Pagliare L et al (2002) Cardiovascular assessment of patients with Ullrich–Turner’s Syndrome on Doppler echo cardiology and magnetic resonance imaging. Arq Bras Cardiol 78(1):51–58
Cripe L, Andelfinger G, Martin LJ, Shooner K, Benson DW (2004) Bicuspid aortic valve is heritable. J Am Coll Cardiol 44:138–143
Gøtzsche CO, Krag-Olsen B, Nielsen J, Sørensen KE, Kristensen BO (1994) Prevalence of cardiovascular malformations and association with karyotypes in Turner’s syndrome. Arch Dis Child 71(5):433–436
Guo DC, Regalado E, Casteel DE, Santos-Cortez RL, Gong L, Kim JJ et al (2013) Recurrent gain-of-function mutation in PRKG1 causes thoracic aortic aneurysms and acute aortic dissections. Am J Hum Genet 93(2):398–404
Guo DC, Gong L, Regalado ES, Santos-Cortez RL, Zhao R, Cai B et al (2015) MAT2A mutations predispose individuals to thoracic aortic aneurysms. Am J Hum Genet 96(1):170–177
Matura LA, Ho VB, Rosing DR, Bondy CA (2007) Aortic dilatation and dissection in Turner syndrome. Circulation 116(15):1663–1670
Mortensen KH, Andersen NH, Gravholt CH (2012) Cardiovascular phenotype in Turner syndrome-integrating cardiology, genetics, and endocrinology. Endocr Rev 33(5):677–714
Muenke M, Kruszka PS, Sable CA, Belmont JW (2012) Congenital heart disease: molecular genetics, principles of diagnosis and treatment. Karger Medical and Scientific Publishers, Basel
Nataatmadja M, West J, Prabowo S, West M (2013) Angiotensin II receptor antagonism reduces transforming growth factor beta and SMAD signaling in thoracic aortic aneurysm. Ochsner J 13(1):42–48
Oliveira RM, Verreschi IT, Lipay MV, Eça LP, Guedes AD, Bianco B (2009) Y chromosome in Turner syndrome: review of the literature. Sao Paulo Med J 127(6):373–378
Pásaro Méndez E, Fernández García RM (2011) Turner syndrome and sex chromosomal mosaicism, advances in the study of genetic disorders, Dr. Kenji Ikehara (Ed). InTech
Prakash SK, Bondy CA, Maslen CL, Silberbach M, Lin AE, Perrone L et al (2016) Autosomal and X chromosome structural variants are associated with congenital heart defects in Turner syndrome: The NHLBI GenTAC registry. Am J Med Genet A 170(12):3157–3164
Ravel C, Siffroi JP (2009) Y chromosome structural abnormalities and Turner’s syndrome. Gynecol Obstet Fertil 37(6):511–518
Stevens A, De Leonibus C, Hanson D, Dowsey AW, Whatmore A, Meyer S et al (2014) Network analysis: a new approach to study endocrine disorders. J Mol Endocrinol 52:R79–R93
Ware SM, Jefferies JL (2012) New genetic insights into congenital heart disease. J Clin Exp Cardiol S8:003
Zhong Q, Layman LC (2012) Genetic considerations in the patient with Turner syndrome—45,X with or without mosaicism. Fertil Steril 98(4):775–779
Acknowledgements
We thank the parents of the girl described for allowing us to share her details.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the reported case.
Additional information
Communicated by S. Hohmann.
Rights and permissions
About this article
Cite this article
Bouayed Abdelmoula, N., Abdelmoula, B., Smaoui, W. et al. Left-sided congenital heart lesions in mosaic Turner syndrome. Mol Genet Genomics 293, 495–501 (2018). https://doi.org/10.1007/s00438-017-1398-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00438-017-1398-x